Effectiveness and Safety of Colistimethate Sodium Used in the Treatment of Neutropenic Blood Cancer Patients Infected with Multidrug-Resistant Pseudomonas aeruginosa.

MLA

Salman, Alaa, et al. “Effectiveness and Safety of Colistimethate Sodium Used in the Treatment of Neutropenic Blood Cancer Patients Infected with Multidrug-Resistant Pseudomonas Aeruginosa.” Arabian Journal for Science & Engineering (Springer Science & Business Media B.V. ), vol. 49, no. 7, July 2024, pp. 9111–20. EBSCOhost, https://doi.org/10.1007/s13369-024-08830-z.

APA

Salman, A., Ghannam, A., Kittaneh, A., Abu-zant, A., Sahoury, Y., Sahouri, E., Abuamsha, R., & Salman, M. (2024). Effectiveness and Safety of Colistimethate Sodium Used in the Treatment of Neutropenic Blood Cancer Patients Infected with Multidrug-Resistant Pseudomonas aeruginosa. Arabian Journal for Science & Engineering (Springer Science & Business Media B.V. ), 49(7), 9111–9120. https://doi.org/10.1007/s13369-024-08830-z

Chicago

Salman, Alaa, Ameera Ghannam, Ala’a Kittaneh, Aladdin Abu-zant, Yousef Sahoury, Ekram Sahouri, Ruba Abuamsha, and Mazen Salman. 2024. “Effectiveness and Safety of Colistimethate Sodium Used in the Treatment of Neutropenic Blood Cancer Patients Infected with Multidrug-Resistant Pseudomonas Aeruginosa.” Arabian Journal for Science & Engineering (Springer Science & Business Media B.V. ) 49 (7): 9111–20. doi:10.1007/s13369-024-08830-z.